Claire Brooks

2.3k total citations
21 papers, 577 citations indexed

About

Claire Brooks is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Claire Brooks has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Claire Brooks's work include Cancer Immunotherapy and Biomarkers (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Glioma Diagnosis and Treatment (3 papers). Claire Brooks is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Glioma Diagnosis and Treatment (3 papers). Claire Brooks collaborates with scholars based in United Kingdom, Spain and Australia. Claire Brooks's co-authors include George Terry, Heather Cubie, Ian Jacobs, G. Hulman, Jack Cuzick, Peter Sasieni, Usha Menon, Robert P. Edwards, Mina Desai and Linda Ho and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Claire Brooks

17 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Brooks United Kingdom 8 374 185 144 71 59 21 577
Silvia de Sanjosé Spain 5 480 1.3× 202 1.1× 158 1.1× 68 1.0× 57 1.0× 6 590
C. James Sung United States 9 153 0.4× 116 0.6× 43 0.3× 99 1.4× 138 2.3× 16 452
A Vergara Spain 11 347 0.9× 211 1.1× 108 0.8× 24 0.3× 54 0.9× 15 471
Jamiyah Hassan Malaysia 17 106 0.3× 104 0.6× 31 0.2× 64 0.9× 50 0.8× 42 684
Melissa Valdez United States 12 251 0.7× 125 0.7× 88 0.6× 385 5.4× 41 0.7× 17 692
Miriam Dellino Italy 18 155 0.4× 126 0.7× 230 1.6× 125 1.8× 56 0.9× 101 985
Talshyn Ukybassova Kazakhstan 10 261 0.7× 77 0.4× 72 0.5× 106 1.5× 39 0.7× 35 674
Samantha Barton United Kingdom 10 155 0.4× 170 0.9× 42 0.3× 57 0.8× 40 0.7× 25 408
Margaret E. Long United States 16 122 0.3× 77 0.4× 92 0.6× 57 0.8× 10 0.2× 46 652
Michaela Veronika Gonfiantini Italy 11 122 0.3× 75 0.4× 23 0.2× 51 0.7× 51 0.9× 38 423

Countries citing papers authored by Claire Brooks

Since Specialization
Citations

This map shows the geographic impact of Claire Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Brooks more than expected).

Fields of papers citing papers by Claire Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Brooks. The network helps show where Claire Brooks may publish in the future.

Co-authorship network of co-authors of Claire Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Brooks. A scholar is included among the top collaborators of Claire Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Brooks. Claire Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Nicholas F., Catherine McBain, Lucy Brazil, et al.. (2025). Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial. Neuro-Oncology Advances. 7(1). vdaf032–vdaf032.
2.
Brooks, Claire, et al.. (2025). Dignity in mental healthcare: service user perspectives. SHILAP Revista de lepidopterología. 2(1).
3.
Mulholland, Paul, Nicholas F. Brown, Catherine McBain, et al.. (2023). A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio.. Journal of Clinical Oncology. 41(17_suppl). LBA2023–LBA2023. 5 indexed citations
4.
5.
Ivbijaro, Gabriel, et al.. (2020). Psychological impact and psychosocial consequences of the COVID 19 pandemicResilience, mental well-being, and the coronavirus pandemic. Indian Journal of Psychiatry. 62(9). 395–395. 45 indexed citations
6.
7.
Jankowski, Janusz, John de Caestecker, Sharon Love, et al.. (2018). Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial.. Journal of Clinical Oncology. 36(18_suppl). LBA4008–LBA4008. 2 indexed citations
8.
Keegan, Thomas, et al.. (2017). Sarin Exposures in A Cohort of British Military Participants in Human Experimental Research at Porton Down 1945–1987. Annals of Work Exposures and Health. 62(1). 17–27. 4 indexed citations
9.
Weaver, Andrew, Sharon Love, Mark Larsen, et al.. (2014). A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes. Supportive Care in Cancer. 22(10). 2677–2685. 23 indexed citations
10.
Jones, Matthew L., Sherina L. Murden, Claire Brooks, et al.. (2013). Disruption of AP3B1by a chromosome 5 inversion: a new disease mechanism in Hermansky-Pudlak syndrome type 2. BMC Medical Genetics. 14(1). 42–42. 37 indexed citations
11.
Nicum, Shibani, Claire Brooks, Rose Wharton, et al.. (2013). Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.. Journal of Clinical Oncology. 31(15_suppl). TPS5615–TPS5615. 1 indexed citations
12.
Carpenter, L, Louise Linsell, Claire Brooks, et al.. (2009). Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study. BMJ. 338(mar24 2). b655–b655. 8 indexed citations
13.
Venables, K M, Claire Brooks, Louise Linsell, et al.. (2009). Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study. BMJ. 338(mar24 2). b613–b613. 7 indexed citations
14.
Carpenter, L, K M Venables, Louise Linsell, et al.. (2009). Mortality and cancer morbidity in a cohort of British military veterans included in chemical warfare agent experiments at Porton Down. Journal of Epidemiology & Community Health. 63(Suppl 2). 47–47. 1 indexed citations
15.
Keegan, Thomas, Sarah Walker, Claire Brooks, et al.. (2009). Exposures Recorded for Participants in the UK Chemical Warfare Agent Human Research Programme, 1941–1989. The Annals of Occupational Hygiene. 53(1). 83–97. 7 indexed citations
16.
Keegan, Thomas, Tony Fletcher, Claire Brooks, et al.. (2007). Reconstructing Exposures from the UK Chemical Warfare Agent Human Research Programme. The Annals of Occupational Hygiene. 51(5). 441–50. 4 indexed citations
17.
18.
Cuzick, Jack, Anne Szarewski, Heather Cubie, et al.. (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART study. The Lancet. 362(9399). 1871–1876. 389 indexed citations
19.
Brooks, Claire. (1998). Radiation Therapy. Physiotherapy. 84(8). 387–395. 1 indexed citations
20.
Brooks, Claire, et al.. (1979). Blood values and the use of ketamine HC1 in the fox.. PubMed. 74(8). 1179–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia de Sanjosé Breakdown of academic impact, for papers by C. James Sung Breakdown of academic impact, for papers by A Vergara Breakdown of academic impact, for papers by Jamiyah Hassan Breakdown of academic impact, for papers by Melissa Valdez Breakdown of academic impact, for papers by Miriam Dellino Breakdown of academic impact, for papers by Talshyn Ukybassova Breakdown of academic impact, for papers by Samantha Barton Breakdown of academic impact, for papers by Margaret E. Long Breakdown of academic impact, for papers by Michaela Veronika Gonfiantini
Rankless by CCL
2026